Group 1: Collaboration and Services - Dingdang Health has formed a significant partnership with Xiansheng Pharmaceutical to launch the insomnia medication Daridorexant (brand name: Kewike) on its O2O platform, providing more medication options for those suffering from sleep disorders [1] - The collaboration aims to offer a comprehensive service that includes instant retail of medications, medication guidance, online health consultations, and health education [1] - Since February, Dingdang Health has partnered with numerous original research pharmaceutical companies to establish the "Original Drug Supply Alliance," enhancing its platform for the launch of new drugs [1] Group 2: Market Potential and Product Approval - The insomnia medication market in China shows significant potential, with nearly half (48.5%) of adults experiencing sleep issues, which increase with age, primarily manifesting as difficulty falling asleep, waking during the night, and early waking [1] - On June 20, Xiansheng Pharmaceutical's insomnia medication (generic name: Daridorexant) was approved for market launch, having previously received approvals in 11 countries including the US, UK, Switzerland, Japan, Canada, and Hong Kong [1] - The introduction of this product on Dingdang Health's platform is expected to provide more effective and safer treatment options for China's large population of insomnia sufferers [1]